Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
for
Multiple Myeloma
Location: Washington D.C. DC, Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT04661137
Phase 2, Recruiting
Circulating Tumor DNA
for
ER+ Breast Cancer
Location: Washington D.C. DC, Baltimore MD, The Bronx NY,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06923527
Phase 2, Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies
for
Cancer
Location: Washington DC, Louisville KY, Houston TX,
Sponsor: Advanced Cancer Therapeutics
Sex: All
Age: 18+
Code: NCT02044861
Phase 1, Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
for
Patients With Non-Small Cell Lung Cancer
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: OSE Immunotherapeutics
Sex: All
Age: 18+
Code: NCT06472245
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
for
Non-small Cell Lung Cancer Stage III
Location: Washington D.C. DC, Charlottesville VA, St Louis MO
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06449313
Phase 2, Recruiting
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Location: Washington D.C. DC, Fairfax VA, New York NY, Canton OH,
Sponsor: Taiho Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07128199
Phase 3, Recruiting
Mosaic Trial for Stem Cell Transplant Recipients
for
Hematologic Malignancy, Stem Cell Transplant,
Location: Washington D.C. DC, Nutley NJ, Chicago IL
Sponsor: Northwestern University
Sex: All
Age: 18+
Code: NCT06960993
Recruiting
New
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
for
Breast Cancer, Diabetes Type II
Location: Washington D.C. DC, Morgantown WV, New York NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07748208
Phase 2, Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
for
Arrythmia, Cardiomyopathies
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05034432
Recruiting
Tracking Results of Ablations to Combat AF Registry Generation 2
for
Atrial Fibrillation
Location: Washington D.C. DC, Brooklyn NY, Poughkeepsie NY,
Sponsor: AtriCure, Inc.
Sex: All
Age: 18+
Code: NCT05111015
Recruiting
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
for
Burns
Location: Washington D.C. DC, Iowa City IA, Phoenix AZ,
Sponsor: Skingenix, Inc.
Sex: All
Age: 18+
Code: NCT01297400
Phase 2, Recruiting
Serranator POINT FORCE Registry
for
Peripheral Artery Disease (PAD), Dysfunctional AV Fistula,
Location: Washington D.C. DC, Philadelphia PA, Marlton NJ,